ADMA BIOLOGICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ADMA BIOLOGICS, INC. (ADMA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of -72.19 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-11-05
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was -24.50K shares, a 162.46% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was -76.77K shares, a 170.59% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 29.09K shares, a 492.89% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was 17.09K shares, a 17.30% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 169.99K shares, a 179.35% increase from fiscal 2018.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 60.85K shares, a 35.28% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 94.02K shares, a 340.72% increase from fiscal 2016.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 21.33K shares, a 119.71% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | -24.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -101.28K shares derived: sum of 2 quarters · filed 2020-11-05 | -72.19K shares 10-Q · filed 2020-11-05 | -55.10K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | -76.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -47.68K shares 10-Q · filed 2020-08-05 | -30.59K shares derived: sum of 3 quarters · filed 2020-08-05 | 8.64K shares derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | 29.09K shares 10-Q · filed 2020-05-06 | 46.18K shares derived: sum of 2 quarters · filed 2020-05-06 | 85.41K shares derived: sum of 3 quarters · filed 2020-05-06 | 194.17K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 17.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 56.33K shares derived: sum of 2 quarters · filed 2020-03-13 | 165.09K shares derived: sum of 3 quarters · filed 2020-03-13 | 169.99K shares 10-K · filed 2020-03-13 |
| 2019-09-30 | 39.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 148.00K shares derived: sum of 2 quarters · filed 2019-11-06 | 152.90K shares 10-Q · filed 2019-11-06 | 167.47K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-06-30 | 108.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 113.67K shares 10-Q · filed 2019-08-08 | 128.24K shares derived: sum of 3 quarters · filed 2020-03-13 | 151.34K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-03-31 | 4.91K shares 10-Q · filed 2019-05-08 | 19.48K shares derived: sum of 2 quarters · filed 2020-03-13 | 42.58K shares derived: sum of 3 quarters · filed 2020-03-13 | 53.26K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-31 | 14.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 37.67K shares derived: sum of 2 quarters · filed 2020-03-13 | 48.35K shares derived: sum of 3 quarters · filed 2020-03-13 | 60.85K shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 23.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 33.78K shares derived: sum of 2 quarters · filed 2018-11-09 | 46.28K shares 10-Q · filed 2018-11-09 | 52.98K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-06-30 | 10.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 23.18K shares 10-Q · filed 2018-08-10 | 29.89K shares derived: sum of 3 quarters · filed 2019-03-13 | 54.37K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-03-31 | 12.50K shares 10-Q · filed 2018-05-14 | 19.20K shares derived: sum of 2 quarters · filed 2019-03-13 | 43.69K shares derived: sum of 3 quarters · filed 2019-03-13 | 86.71K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-12-31 | 6.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 31.19K shares derived: sum of 2 quarters · filed 2019-03-13 | 74.21K shares derived: sum of 3 quarters · filed 2019-03-13 | 94.02K shares 10-K · filed 2019-03-13 |
| 2017-09-30 | 24.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 67.51K shares derived: sum of 2 quarters · filed 2017-11-03 | 87.32K shares 10-Q · filed 2017-11-03 | 87.32K shares derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-06-30 | 43.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 62.84K shares 10-Q · filed 2017-08-11 | 62.84K shares derived: sum of 3 quarters · filed 2018-03-29 | 62.84K shares derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-03-31 | 19.81K shares 10-Q · filed 2017-05-12 | 19.81K shares derived: sum of 2 quarters · filed 2018-03-29 | 19.81K shares derived: sum of 3 quarters · filed 2018-03-29 | 38.56K shares derived: sum of 4 quarters · filed 2018-03-29 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-29 | 18.75K shares derived: sum of 3 quarters · filed 2018-03-29 | 21.33K shares 10-K · filed 2018-03-29 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 18.75K shares derived: sum of 2 quarters · filed 2016-11-10 | 21.33K shares 10-Q · filed 2016-11-10 | 40.75K shares derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-06-30 | 18.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 21.33K shares 10-Q · filed 2016-08-12 | 40.75K shares derived: sum of 3 quarters · filed 2017-02-24 | 40.75K shares derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-03-31 | 2.58K shares 10-Q · filed 2016-05-13 | 22.00K shares derived: sum of 2 quarters · filed 2017-02-24 | 22.00K shares derived: sum of 3 quarters · filed 2017-02-24 | 13.13K shares derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-12-31 | 19.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | 19.42K shares derived: sum of 2 quarters · filed 2017-02-24 | 10.54K shares derived: sum of 3 quarters · filed 2017-02-24 | 9.71K shares 10-K · filed 2017-02-24 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -8.88K shares derived: sum of 2 quarters · filed 2015-11-10 | -9.71K shares 10-Q · filed 2015-11-10 | -9.71K shares derived: sum of 4 quarters · filed 2016-03-23 |
| 2015-06-30 | -8.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -9.71K shares 10-Q · filed 2015-08-11 | -9.71K shares derived: sum of 3 quarters · filed 2016-03-23 | -9.71K shares derived: sum of 4 quarters · filed 2016-03-23 |
| 2015-03-31 | -835.00 shares 10-Q · filed 2015-05-12 | -835.00 shares derived: sum of 2 quarters · filed 2016-03-23 | -835.00 shares derived: sum of 3 quarters · filed 2016-03-23 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-23 | 0.00 shares 10-K · filed 2016-03-23 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 0.00 shares 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-11 | |||
| 2013-12-31 | -6.35K shares 10-K · filed 2015-03-09 | |||
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-28 | |||
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |